All News

Researchers at Duke University found there is substantial room for improvement in providing consumers with ready access to healthcare prices online.

A woman gives birth after receivng a uterine transplant for the first time in the US; a once-monthly treatment for patients with poioid addiction gains FDA approval; and LA public health officials launch an initiative to reduce the annual number HIV infections.

Republican leaders begin work Monday reconciling the differences in the Senate and House tax legislation, hoping to send a final bill to President Trump before Christmas. Senate Republicans passed the bill by 51-49 just before 2 am on Saturday.

CVS Health has proposed purchasing health insurer Aetna in a $69 billion deal that could disrupt the pharmacy benefit management business and "remake the consumer healthcare experience," according to CVS Health's president and CEO.

Federally qualified health centers (FQHCs) saw the benefit of funding from an American Cancer Society (ACS) program aimed at strengthening colorectal cancer screening rates over a 3-year period.

Researchers find brake mechanism that prevents an essential shell from forming on virus that causes AIDS.

CMS is focusing on patient empowerment and unburdening physicians, said CMS Administrator Seema Verma during her keynote speech at the Office of the National Coordinator for Health Information Technology’s Annual Meeting.

Trastuzumab-dkst is the first biosimilar approved in the US for treating breast cancer or stomach cancer and the second biosimilar approved in the US for the treatment of cancer.

The FDA update was based on results of the FOURIER trial, which showed the drug reduced the risk of heart attacks, strokes, and revascularizations in high-risk patients.

Countries in Southern and Eastern Africa have the highest prevalence of HIV worldwide. The Joint United Nations Program on HIV/AIDS strategy to end AIDS by 2030 has been dedicated to preventing HIV through voluntary medical male circumcision in Southern and Eastern African countries with HIV epidemics and low male circumcision prevalence.

A newly published retrospective study in The Annals of Thoracic Surgery found that lobectomy improved survival in patients with early-stage lung cancer compared with SBRT.

Panelists at the Office of the National Coordinator for Health Information Technology (IT)’s Annual Meeting discussed their perspectives on health IT innovation and expectations for 2018.

With the increasing emergence of less expensive biologic alternatives, some health systems are making the switch. For a large healthcare system, the arrival of a cheaper alternative to filgrastim prompted the conversion to using tbo-filgrastim as the preferrred granulocyte-colony stimulating factor. The results were shared in a study published by the Journal of Managed Care & Specialty Pharmacy.

This week, the top managed care news included a new proposal from CMS that insurers warn will cause confusion; a new review examines the prevalence and cost of chronic conditions in Medicaid; and a study finds 42% of all new US cancer cases in 2014 were due to potentially modifiable exposures.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A growing number of clinicians specializing in nursing home care indicates the beginning of a new trend in healthcare, but the impact of these new specialists on outcomes remains unclear.

Flu season in North America is off to an early start; exercising regularly might not offset a generally sedentary lifestyle; short-term health plans are being packaged to circumvent Obamacare restrictions.

Records show that in 2016, there was an average of 1 healthcare data breach per day, and consumers are responding to these reports.

The gap between patients and technology can be overcome with workforce ready to handle innovation and communicate value to patients.

Scaling back the Comprehensive Care for Joint Replacement model and canceling an expansion proposed under the Obama administration represents a shift in philosophy from mandatory to voluntary bundled payment models. But some say that commercial payers and employers will demand change no matter what CMS does.

A recent study indicates that parents are able to take high-quality photos of their child's skin condition to send to a dermatologist for an accurate diagnosis.

Alex Azar faces skepticism regarding his ability to regulate drug prices given his past employment; Kellyanne Conway is named America's opioid czar; a study finds childhood trauma can have a generational impact.

Liver and endometrial cancer accounted for high numbers of new cases; increases of these cancer types have been attributed to rising rates of diabetes and obesity.

The immunotherapy drug pembrolizumab has demonstrated manageable side effects and durable antitumor activity in patients with heavily pretreated, advanced esophageal cancer. The immunotherapy drug results, released from the KEYNOTE-028 trial, showed an overall response rate of 30%.

After a year-long process, Shawnee Mission Health (SMH) is now a certified member of the MD Anderson Cancer Network, the top ranked cancer center in the US. The 2 will work together to raise the standard of cancer care in the Kansas City metropolitan community through patient-centered care.

Analysis of the results from an early phase multicenter study have found that while ipilimumab is safe in women with metastatic or recurrent cervical cancer, it did not improve patient response to treatment.

In an interview with The American Journal of Managed Care®, Kashyap Patel, MD, Carolina Blood and Cancer Care, discussed risk factors that contribute to the development of neutropenia, how to minimize the risk of development, the effects of neutropenia, and what he recommends to patients who have been treated for the condition.

Brain magnetic resonance imaging (MRI) can be used to identify people with attention-deficit/hyperactivity disorder from patients without the condition, according to a new study.

While African Americans are 3 times more likely than Caucasians to be diagnosed with multiple myeloma (MM)—and twice as likely to die of the disease—they are underrepresented in MM disease research.